Go Pro
→ The ultimate IPO unicorn (From Weiss Ratings) (Ad)tc pixel Free ADUS Stock Alerts

Addus HomeCare (ADUS) Financials

Addus HomeCare logo
$119.52 -0.16 (-0.13%)
As of 12:07 PM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare
Annual Income Statements for Addus HomeCare

Annual Income Statements for Addus HomeCare

This table shows Addus HomeCare's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 12 12 12 16 25 33 45 46 63 74 96
Consolidated Net Income / (Loss)		 12 12 12 16 25 33 45 46 63 74 96
Net Income / (Loss) Continuing Operations		 11 12 12 16 26 33 45 46 63 74 96
Total Pre-Tax Income 		15 16 21 20 33 42 60 60 81 99 127
Total Operating Income		 16 15 25 23 35 45 66 69 91 103 139
Total Gross Profit		 87 99 116 137 179 226 270 300 340 375 462
Total Revenue		 337 401 426 517 649 765 864 951 1,059 1,155 1,423
Operating Revenue		 337 401 426 517 649 765 864 951 1,059 1,155 1,423
Total Cost of Revenue		 250 302 310 380 470 539 595 651 719 780 961
Operating Cost of Revenue		 245 295 310 380 470 539 595 651 719 780 961
Total Operating Expenses		 71 83 91 114 144 182 204 231 249 272 323
Selling, General & Admin Expense		 66 77 77 105 134 170 189 217 235 259 307
Depreciation Expense		 4.72 6.65 6.66 8.64 11 12 14 14 14 14 16
Total Other Income / (Expense), net		 -0.74 0.69 -4.19 -2.42 -1.58 -2.57 -5.54 -8.57 -9.63 -3.34 -11
Interest Expense		 0.79 2.33 4.47 5.02 3.11 3.19 5.81 8.91 11 7.73 14
Interest & Investment Income		 0.05 2.81 0.07 2.59 1.52 0.62 0.27 0.34 1.48 4.39 2.44
Income Tax Expense		 3.93 4.10 9.26 4.10 7.36 8.81 15 14 19 26 32
Basic Earnings per Share		 $1.06 $1.07 $1.04 $1.36 $1.83 $2.12 $2.87 $2.90 $3.91 $4.33 $5.31
Weighted Average Basic Shares Outstanding		 10.99M 11.29M 11.47M 12.05M 13.82M 15.60M 15.74M 15.86M 16.00M 17.01M 18.05M
Diluted Earnings per Share		 $1.04 $1.07 $1.03 $1.33 $1.77 $2.08 $2.81 $2.84 $3.83 $4.23 $5.22
Weighted Average Diluted Shares Outstanding		 11.19M 11.35M 11.62M 12.38M 14.25M 15.96M 16.06M 16.18M 16.31M 17.38M 18.39M
Weighted Average Basic & Diluted Shares Outstanding		 11M 11.30M 11.50M 12.10M 13.82M 15.60M 15.95M 16.13M 16.23M 18.17M 18.52M

Quarterly Income Statements for Addus HomeCare

This table shows Addus HomeCare's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
Net Income / (Loss) Attributable to Common Shareholders		 20 16 18 20 20 21 22 23 30 25 28
Consolidated Net Income / (Loss)		 20 16 18 20 20 21 22 23 30 25 28
Net Income / (Loss) Continuing Operations		 20 16 18 20 20 21 22 23 30 25 28
Total Pre-Tax Income 		25 21 25 27 26 27 30 30 40 32 38
Total Operating Income		 28 24 26 26 27 31 33 33 42 34 39
Total Gross Profit		 92 88 93 92 101 108 114 117 124 116 122
Total Revenue		 276 281 287 290 297 338 349 362 373 364 377
Operating Revenue		 276 281 287 290 297 338 349 362 373 364 377
Total Cost of Revenue		 184 193 194 198 196 230 236 246 249 248 256
Operating Cost of Revenue		 184 193 194 198 196 230 236 246 249 248 256
Total Operating Expenses		 64 65 67 66 75 77 81 84 81 82 83
Selling, General & Admin Expense		 61 61 64 63 71 73 77 79 77 78 78
Depreciation Expense		 3.68 3.47 3.40 3.45 3.21 3.94 3.91 4.41 4.15 4.03 4.13
Total Other Income / (Expense), net		 -2.62 -2.34 -1.64 1.34 -0.70 -3.52 -2.94 -2.58 -2.13 -1.64 -1.16
Interest Expense		 3.12 2.76 2.11 0.57 2.29 4.02 3.53 3.34 2.73 2.15 1.72
Interest & Investment Income		 0.50 0.42 0.47 1.91 1.59 0.50 0.58 0.76 0.60 0.51 0.57
Income Tax Expense		 5.78 5.48 6.46 7.13 6.69 5.77 7.89 7.51 10 7.36 10
Basic Earnings per Share		 $1.23 $0.99 $1.12 $1.13 $1.09 $1.18 $1.22 $1.26 $1.65 $1.38 $1.51
Weighted Average Basic Shares Outstanding		 16.00M 16.06M 16.18M 17.87M 17.01M 17.98M 18.05M 18.07M 18.05M 18.19M 18.29M
Diluted Earnings per Share		 $1.19 $0.97 $1.10 $1.10 $1.06 $1.16 $1.20 $1.24 $1.62 $1.36 $1.49
Weighted Average Diluted Shares Outstanding		 16.31M 16.37M 16.50M 18.26M 17.38M 18.31M 18.33M 18.39M 18.39M 18.49M 18.47M
Weighted Average Basic & Diluted Shares Outstanding		 16.23M 16.37M 18.10M 18.13M 18.17M 18.40M 18.41M 18.48M 18.52M 18.66M 18.67M

Annual Cash Flow Statements for Addus HomeCare

This table details how cash moves in and out of Addus HomeCare's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents		 -9.26 3.91 46 17 41 33 24 -89 -15 34 -17
Net Cash From Operating Activities		 4.11 -0.74 53 33 12 109 39 105 112 116 112
Net Cash From Continuing Operating Activities		 4.11 -0.74 53 33 12 109 39 105 112 116 112
Net Income / (Loss) Continuing Operations		 12 12 12 16 25 33 45 46 63 74 96
Consolidated Net Income / (Loss)		 12 12 12 16 25 33 45 46 63 74 96
Depreciation Expense		 4.72 6.65 6.66 8.64 11 12 14 14 14 14 16
Amortization Expense		 0.10 0.36 1.87 0.61 0.72 0.74 0.80 0.86 0.86 1.05 1.29
Non-Cash Adjustments To Reconcile Net Income		 6.01 11 9.99 4.42 6.11 28 -18 21 3.46 19 18
Changes in Operating Assets and Liabilities, net		 -18 -31 22 3.10 -31 36 -3.42 23 31 9.22 -21
Net Cash From Investing Activities		 -11 -22 -24 -68 -189 -214 -42 -107 -119 -355 -33
Net Cash From Continuing Investing Activities		 -11 -22 -24 -68 -189 -214 -42 -107 -119 -355 -33
Purchase of Property, Plant & Equipment		 -2.21 -1.71 -3.62 -5.35 -4.62 -6.83 -4.65 -8.30 -9.45 -6.05 -7.72
Acquisitions		 -8.51 -20 -24 -62 -184 -208 -37 -98 -110 -354 -32
Sale of Property, Plant & Equipment		 - - 3.70 - - - 0.00 0.00 0.02 0.03 0.02
Divestitures		 - - - 0.00 0.00 0.26 0.00 0.00 0.00 5.36 6.79
Net Cash From Financing Activities		 -2.64 26 17 51 218 138 26 -87 -8.18 272 -96
Net Cash From Continuing Financing Activities		 -2.64 26 17 51 218 138 26 -87 -8.18 272 -96
Repayment of Debt		 -2.22 -30 -77 -106 -1.11 -0.74 -21 -137 -119 -140 -110
Issuance of Debt		 - 52 95 80 43 135 46 47 110 233 11
Issuance of Common Equity		 - - 0.00 77 173 0.00 0.00 0.00 0.00 176 0.00
Other Financing Activities, net		 -0.43 4.01 -0.27 -0.02 3.09 3.92 1.11 2.55 0.32 3.44 2.48
Cash Interest Paid		 0.79 2.32 2.26 4.34 2.32 2.37 5.09 7.99 10 6.52 12
Cash Income Taxes Paid		 0.91 5.09 6.73 4.10 7.30 11 18 1.48 15 26 13

Quarterly Cash Flow Statements for Addus HomeCare

This table details how cash moves in and out of Addus HomeCare's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
Net Change in Cash & Equivalents		 -15 12 97 50 -124 -1.96 -5.78 11 -20 21 -3.50
Net Cash From Operating Activities		 30 39 19 49 10 19 23 51 19 52 40
Net Cash From Continuing Operating Activities		 30 39 19 49 10 19 23 51 19 52 40
Net Income / (Loss) Continuing Operations		 20 16 18 20 20 21 22 23 30 25 28
Consolidated Net Income / (Loss)		 20 16 18 20 20 21 22 23 30 25 28
Depreciation Expense		 3.68 3.47 3.40 3.45 3.21 3.94 3.91 4.41 4.15 4.03 4.13
Amortization Expense		 0.22 0.22 0.22 0.21 0.41 0.32 0.32 0.33 0.33 0.33 0.33
Non-Cash Adjustments To Reconcile Net Income		 0.64 11 2.57 3.81 2.03 0.98 3.99 2.52 11 8.29 2.54
Changes in Operating Assets and Liabilities, net		 5.94 8.54 -5.46 21 -15 -7.52 -7.74 21 -26 15 5.41
Net Cash From Investing Activities		 -5.30 -1.75 3.55 -1.92 -354 -1.38 1.70 -23 -10 -1.69 -14
Net Cash From Continuing Investing Activities		 -5.30 -1.75 3.55 -1.92 -354 -1.38 1.70 -23 -10 -1.69 -14
Purchase of Property, Plant & Equipment		 -5.32 -1.35 -1.07 -1.93 -1.70 -1.88 -1.25 -1.92 -2.66 -1.71 -1.34
Acquisitions		 0.00 -0.40 - - -354 -3.35 - -21 -7.40 0.00 -12
Sale of Property, Plant & Equipment		 0.02 0.00 - 0.01 - 0.01 0.01 -0.01 0.01 0.02 0.02
Net Cash From Financing Activities		 -40 -25 74 2.94 220 -20 -30 -18 -29 -29 -30
Net Cash From Continuing Financing Activities		 -40 -25 74 2.94 220 -20 -30 -18 -29 -29 -30
Repayment of Debt		 -40 -25 -101 -0.04 -13 -20 -30 -30 -30 -30 -30
Cash Interest Paid		 2.89 2.53 1.96 0.31 1.72 3.74 3.28 3.05 2.39 1.80 1.42
Cash Income Taxes Paid		 4.42 0.01 14 5.45 6.82 -0.01 4.87 4.38 3.38 0.00 5.29

Annual Balance Sheets for Addus HomeCare

This table presents Addus HomeCare's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets		 186 230 272 348 637 893 948 938 1,024 1,413 1,437
Total Current Assets		 94 131 156 176 269 288 324 223 200 260 269
Cash & Equivalents		 4.10 8.01 54 70 112 145 169 80 65 99 82
Accounts Receivable		 85 117 94 98 150 133 137 126 115 123 152
Prepaid Expenses		 4.86 6.00 8.38 7.29 7.99 9.97 18 17 20 39 36
Plant, Property, & Equipment, net		 8.62 6.65 7.49 11 12 20 18 21 24 25 25
Total Noncurrent Assets		 83 92 109 161 355 585 605 694 800 1,128 1,143
Goodwill		 69 73 90 135 275 469 504 583 663 971 997
Intangible Assets		 10 15 17 24 57 72 64 72 92 110 102
Other Noncurrent Operating Assets		 1.34 - - 0.00 21 38 36 39 45 47 44
Total Liabilities & Shareholders' Equity		 186 230 272 348 637 893 948 938 1,024 1,413 1,437
Total Liabilities		 44 72 95 80 161 374 373 304 318 442 352
Total Current Liabilities		 42 50 55 62 88 144 118 131 145 156 149
Accounts Payable		 4.75 4.49 7.38 12 20 24 19 22 26 27 17
Accrued Expenses		 35 43 45 34 53 73 81 72 90 91 94
Current Employee Benefit Liabilities		 - - - 15 14 14 13 13 12 14 14
Other Current Liabilities		 1.25 - - - 0.00 32 4.17 24 17 24 25
Total Noncurrent Liabilities		 1.88 22 40 18 74 230 256 173 173 286 203
Long-Term Debt		 1.88 22 40 17 59 194 221 132 124 218 121
Noncurrent Deferred & Payable Income Tax Liabilities		 - - - - - - 0.00 0.00 8.53 26 44
Other Noncurrent Operating Liabilities		 - - 0.45 0.88 14 36 35 42 40 42 37
Total Equity & Noncontrolling Interests		 142 158 176 268 476 519 574 634 707 970 1,085
Total Preferred & Common Equity		 142 158 176 268 476 519 574 634 707 970 1,085
Total Common Equity		 142 158 176 268 476 519 574 634 707 970 1,085
Common Stock		 87 92 96 178 360 370 380 393 404 594 613
Retained Earnings		 55 65 80 91 116 149 194 240 303 376 472

Quarterly Balance Sheets for Addus HomeCare

This table presents Addus HomeCare's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026
Period end date 3/31/2023 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026 6/30/2026
Total Assets		 931 928 1,036 1,014 1,117 1,153 1,408 1,409 1,423 1,436 1,456
Total Current Assets		 209 208 211 192 295 333 258 263 261 273 284
Cash & Equivalents		 74 84 80 77 173 223 97 91 102 103 100
Accounts Receivable		 125 104 121 105 109 97 135 140 134 145 145
Prepaid Expenses		 10 19 10 10 12 13 26 32 25 25 39
Plant, Property, & Equipment, net		 20 20 21 24 23 24 25 24 24 25 24
Total Noncurrent Assets		 702 701 804 798 798 796 1,125 1,121 1,138 1,138 1,148
Goodwill		 584 584 663 663 664 664 972 970 989 997 1,008
Intangible Assets		 71 69 94 90 88 87 108 106 104 100 99
Other Noncurrent Operating Assets		 47 48 47 45 46 46 45 46 45 41 41
Total Liabilities & Shareholders' Equity		 931 928 1,036 1,014 1,117 1,153 1,408 1,409 1,423 1,436 1,456
Total Liabilities		 282 262 351 289 195 205 412 387 373 320 308
Total Current Liabilities		 125 134 140 142 148 158 148 151 157 149 168
Accounts Payable		 22 21 21 22 20 28 28 16 17 14 18
Accrued Expenses		 68 80 87 83 91 92 85 101 107 94 112
Current Employee Benefit Liabilities		 13 12 12 12 12 13 14 13 14 13 13
Other Current Liabilities		 22 21 19 25 24 25 21 21 19 28 25
Total Noncurrent Liabilities		 158 128 212 147 47 47 264 236 216 170 140
Long-Term Debt		 108 79 164 99 0.00 0.00 199 169 151 91 62
Noncurrent Deferred & Payable Income Tax Liabilities		 - - - - - - 26 26 26 44 44
Other Noncurrent Operating Liabilities		 49 49 48 48 47 47 40 40 39 35 34
Total Equity & Noncontrolling Interests		 649 666 684 725 922 948 995 1,022 1,050 1,116 1,148
Total Preferred & Common Equity		 649 666 684 725 922 948 995 1,022 1,050 1,116 1,148
Total Common Equity		 649 666 684 725 922 948 995 1,022 1,050 1,116 1,148
Common Stock		 396 399 401 406 585 591 598 602 607 619 623
Retained Earnings		 253 268 283 319 337 357 398 420 443 497 525

Annual Metrics And Ratios for Addus HomeCare

This table displays calculated financial ratios and metrics derived from Addus HomeCare's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 7.63% 19.04% 6.25% 21.28% 25.58% 17.88% 13.04% 10.02% 11.31% 9.06% 23.21%
EBITDA Growth		 -5.52% 8.87% 49.87% -5.66% 43.54% 24.44% 41.78% 2.98% 26.64% 10.69% 33.30%
EBIT Growth		 -11.33% -2.13% 62.42% -10.38% 52.24% 28.07% 48.15% 4.25% 32.32% 12.90% 34.98%
NOPAT Growth		 -4.25% -2.95% 22.53% 28.90% 48.22% 30.02% 40.12% 6.73% 32.98% 8.80% 37.13%
Net Income Growth		 -5.06% 4.62% -1.70% 37.48% 53.58% 31.29% 36.20% 1.99% 35.83% 17.73% 30.32%
EPS Growth		 -5.45% 2.88% -3.74% 29.13% 33.08% 17.51% 35.10% 1.07% 34.86% 10.44% 23.40%
Operating Cash Flow Growth		 -41.58% -118.10% 7,202.42% -37.08% -63.80% 810.32% -63.91% 166.18% 6.79% 3.73% -4.23%
Free Cash Flow Firm Growth		 -38.77% -116.14% 199.57% -240.48% -473.73% 39.60% 92.12% 25.67% -67.87% -2,202.93% 128.11%
Invested Capital Growth		 19.05% 24.44% -4.80% 30.12% 96.76% 34.15% 10.18% 9.42% 11.77% 42.29% 3.18%
Revenue Q/Q Growth		 0.63% 5.01% 2.00% 5.29% 9.11% 0.48% 3.43% 2.41% 2.85% 1.83% 5.64%
EBITDA Q/Q Growth		 -9.33% 33.25% -2.73% -3.33% 29.41% -4.73% 11.52% 1.27% 7.45% -1.12% 11.58%
EBIT Q/Q Growth		 -12.20% 48.55% -4.33% -5.10% 35.97% -5.95% 13.11% 2.16% 8.54% -1.02% 12.47%
NOPAT Q/Q Growth		 -4.18% 27.31% -24.63% 16.43% 33.69% -5.45% 11.51% 5.29% 7.37% -1.95% 12.16%
Net Income Q/Q Growth		 -4.92% 56.36% -33.86% 13.95% 39.45% -6.46% 11.38% 3.84% 8.35% -0.07% 11.97%
EPS Q/Q Growth		 -4.59% 55.07% -34.39% 10.83% 33.08% -7.56% 11.07% 2.90% 8.19% -2.98% 12.02%
Operating Cash Flow Q/Q Growth		 -50.07% -102.82% 386.64% -4.79% -27.63% 41.66% -21.65% -0.86% 5.41% -14.43% 8.09%
Free Cash Flow Firm Q/Q Growth		 -992.96% -2,727.78% 244.23% 13.18% -271.42% -53.98% 95.29% -279.90% 64.85% -304.39% 124.81%
Invested Capital Q/Q Growth		 11.58% 28.71% -2.33% -2.79% 45.83% 42.50% 0.00% 1.87% -0.32% 50.39% 2.36%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 25.83% 24.68% 27.20% 26.48% 27.63% 29.58% 31.21% 31.51% 32.10% 32.48% 32.47%
EBITDA Margin		 6.19% 5.66% 7.98% 6.21% 7.10% 7.49% 9.40% 8.80% 10.01% 10.16% 10.99%
Operating Margin		 4.76% 3.86% 5.93% 4.42% 5.36% 5.82% 7.63% 7.23% 8.59% 8.89% 9.74%
EBIT Margin		 4.76% 3.91% 5.98% 4.42% 5.36% 5.82% 7.63% 7.23% 8.59% 8.89% 9.74%
Profit (Net Income) Margin		 3.45% 3.03% 2.81% 3.18% 3.89% 4.33% 5.22% 4.84% 5.91% 6.37% 6.74%
Tax Burden Percent		 76.04% 75.24% 56.75% 80.54% 76.08% 79.00% 74.71% 76.49% 76.87% 74.08% 75.26%
Interest Burden Percent		 95.39% 103.06% 82.70% 89.38% 95.45% 94.24% 91.60% 87.54% 89.41% 96.75% 91.94%
Effective Tax Rate		 25.72% 25.36% 43.95% 20.08% 22.19% 21.00% 25.29% 23.51% 23.13% 25.92% 24.74%
Return on Invested Capital (ROIC)		 9.26% 7.37% 8.34% 9.58% 8.46% 7.09% 8.25% 8.02% 9.63% 8.20% 9.42%
ROIC Less NNEP Spread (ROIC-NNEP)		 13.68% 16.01% -74.63% 15.25% 11.90% 206.92% 0.12% -4.60% -3.69% 5.43% -1.16%
Return on Net Nonoperating Assets (RNNOA)		 -0.64% 0.75% -1.19% -2.19% -1.68% -0.42% 0.01% -0.40% -0.31% 0.58% -0.09%
Return on Equity (ROE)		 8.62% 8.12% 7.16% 7.39% 6.78% 6.66% 8.26% 7.62% 9.33% 8.78% 9.33%
Cash Return on Invested Capital (CROIC)		 -8.13% -14.41% 13.26% -16.60% -56.75% -22.08% -1.44% -0.98% -1.48% -26.71% 6.29%
Operating Return on Assets (OROA)		 8.74% 7.55% 10.16% 7.37% 7.06% 5.82% 7.17% 7.29% 9.27% 8.43% 9.73%
Return on Assets (ROA)		 6.34% 5.85% 4.77% 5.30% 5.13% 4.33% 4.90% 4.88% 6.37% 6.04% 6.73%
Return on Common Equity (ROCE)		 8.62% 8.12% 7.16% 7.39% 6.78% 6.66% 8.26% 7.62% 9.33% 8.78% 9.33%
Return on Equity Simple (ROE_SIMPLE)		 8.20% 7.71% 6.78% 6.12% 5.31% 6.39% 7.86% 7.26% 8.85% 7.58% 0.00%
Net Operating Profit after Tax (NOPAT)		 12 12 14 18 27 35 49 53 70 76 104
NOPAT Margin		 3.53% 2.88% 3.32% 3.53% 4.17% 4.60% 5.70% 5.53% 6.60% 6.59% 7.33%
Net Nonoperating Expense Percent (NNEP)		 -4.42% -8.65% 82.97% -5.67% -3.44% -199.83% 8.13% 12.62% 13.32% 2.76% 10.58%
Return On Investment Capital (ROIC_SIMPLE)		 - - - - - - - 6.87% 8.42% 6.40% 8.65%
Cost of Revenue to Revenue		 74.17% 75.32% 72.80% 73.52% 72.37% 70.42% 68.79% 68.49% 67.90% 67.52% 67.53%
SG&A Expenses to Revenue		 19.64% 19.17% 18.05% 20.39% 20.64% 22.19% 21.91% 22.81% 22.18% 22.41% 21.57%
R&D to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 21.08% 20.82% 21.27% 22.06% 22.27% 23.76% 23.59% 24.29% 23.51% 23.59% 22.72%
Earnings before Interest and Taxes (EBIT)		 16 16 25 23 35 45 66 69 91 103 139
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 21 23 34 32 46 57 81 84 106 117 156
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 1.82 2.55 2.30 3.31 3.18 3.57 2.59 2.53 2.13 2.34 1.83
Price to Tangible Book Value (P/TBV)		 4.14 5.76 5.83 8.14 10.57 0.00 264.50 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)		 0.77 1.00 0.95 1.72 2.33 2.42 1.72 1.69 1.42 1.97 1.40
Price to Earnings (P/E)		 22.25 33.04 33.86 54.11 59.94 55.87 33.00 34.83 24.08 30.88 20.70
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 4.49% 3.03% 2.95% 1.85% 1.67% 1.79% 3.03% 2.87% 4.15% 3.24% 4.83%
Enterprise Value to Invested Capital (EV/IC)		 1.84 2.40 2.38 3.88 3.45 3.34 2.46 2.41 2.04 2.19 1.80
Enterprise Value to Revenue (EV/Rev)		 0.76 1.04 0.92 1.62 2.25 2.49 1.78 1.74 1.48 2.07 1.42
Enterprise Value to EBITDA (EV/EBITDA)		 12.31 18.42 11.59 26.06 31.73 33.18 18.97 19.78 14.77 20.40 12.95
Enterprise Value to EBIT (EV/EBIT)		 16.01 26.65 15.47 36.62 42.04 42.71 23.38 24.07 17.20 23.30 14.60
Enterprise Value to NOPAT (EV/NOPAT)		 21.56 36.18 27.84 45.82 54.02 54.06 31.29 31.47 22.38 31.45 19.41
Enterprise Value to Operating Cash Flow (EV/OCF)		 62.49 0.00 7.47 25.18 121.55 17.37 39.03 15.74 13.94 20.55 18.15
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 17.51 0.00 0.00 0.00 0.00 0.00 0.00 0.00 29.04
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.02 0.16 0.24 0.06 0.13 0.38 0.38 0.21 0.18 0.23 0.11
Long-Term Debt to Equity		 0.01 0.14 0.23 0.06 0.12 0.37 0.38 0.21 0.18 0.23 0.11
Financial Leverage		 -0.05 0.05 0.02 -0.14 -0.14 0.00 0.09 0.09 0.08 0.11 0.08
Leverage Ratio		 1.36 1.39 1.50 1.39 1.32 1.54 1.68 1.56 1.46 1.45 1.39
Compound Leverage Factor		 1.30 1.43 1.24 1.25 1.26 1.45 1.54 1.37 1.31 1.41 1.27
Debt to Total Capital		 2.07% 13.69% 19.59% 6.05% 11.18% 27.31% 27.78% 17.22% 14.94% 18.37% 10.03%
Short-Term Debt to Total Capital		 0.77% 1.38% 1.41% 0.02% 0.14% 0.14% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 1.30% 12.30% 18.18% 6.03% 11.05% 27.17% 27.78% 17.22% 14.94% 18.37% 10.03%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 97.93% 86.31% 80.41% 93.95% 88.82% 72.69% 72.22% 82.78% 85.06% 81.63% 89.97%
Debt to EBITDA		 0.14 1.10 1.26 0.54 1.30 3.40 2.72 1.58 1.17 1.86 0.77
Net Debt to EBITDA		 -0.10 0.71 -0.32 -1.66 -1.13 0.87 0.64 0.62 0.56 1.02 0.25
Long-Term Debt to EBITDA		 0.09 0.99 1.17 0.54 1.29 3.38 2.72 1.58 1.17 1.86 0.77
Debt to NOPAT		 0.25 2.17 3.04 0.95 2.21 5.54 4.48 2.51 1.78 2.87 1.16
Net Debt to NOPAT		 -0.17 1.39 -0.76 -2.91 -1.92 1.42 1.06 0.99 0.85 1.57 0.38
Long-Term Debt to NOPAT		 0.16 1.95 2.82 0.94 2.19 5.51 4.48 2.51 1.78 2.87 1.16
Altman Z-Score		 6.36 6.14 5.28 9.16 7.43 4.42 4.08 4.89 4.65 4.60 5.25
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 2.23 2.64 2.83 2.86 3.08 2.00 2.76 1.70 1.38 1.67 1.80
Quick Ratio		 2.11 2.52 2.67 2.74 2.99 1.93 2.60 1.57 1.24 1.42 1.56
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -10 -23 23 -32 -181 -110 -8.63 -6.41 -11 -248 70
Operating Cash Flow to CapEx		 185.54% -43.40% 0.00% 620.73% 260.10% 1,601.68% 850.12% 1,266.39% 1,189.18% 1,933.80% 1,447.39%
Free Cash Flow to Firm to Interest Expense		 -13.30 -9.69 5.03 -6.30 -58.41 -34.35 -1.49 -0.72 -0.97 -32.06 5.12
Operating Cash Flow to Interest Expense		 5.22 -0.32 11.80 6.62 3.87 34.31 6.80 11.80 10.11 15.06 8.19
Operating Cash Flow Less CapEx to Interest Expense		 2.41 -1.05 11.82 5.55 2.38 32.17 6.00 10.87 9.26 14.28 7.63
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 1.84 1.93 1.70 1.67 1.32 1.00 0.94 1.01 1.08 0.95 1.00
Accounts Receivable Turnover		 4.39 3.97 4.05 5.39 5.23 5.42 6.41 7.25 8.79 9.69 10.36
Inventory Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover		 41.29 52.52 60.27 56.94 56.88 47.94 45.22 47.96 46.85 47.40 57.24
Accounts Payable Turnover		 57.43 65.40 52.27 38.72 29.46 24.85 27.62 31.43 29.78 29.22 43.66
Days Sales Outstanding (DSO)		 83.06 91.93 90.19 67.77 69.76 67.37 56.91 50.36 41.55 37.68 35.23
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)		 6.36 5.58 6.98 9.43 12.39 14.69 13.22 11.61 12.26 12.49 8.36
Cash Conversion Cycle (CCC)		 76.70 86.35 83.21 58.34 57.37 52.68 43.70 38.75 29.29 25.19 26.87
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 140 174 166 215 424 568 626 685 766 1,090 1,125
Invested Capital Turnover		 2.62 2.56 2.51 2.71 2.03 1.54 1.45 1.45 1.46 1.24 1.28
Increase / (Decrease) in Invested Capital		 22 34 -8.35 50 208 145 58 59 81 324 35
Enterprise Value (EV)		 257 418 394 836 1,461 1,901 1,541 1,655 1,565 2,393 2,024
Market Capitalization		 259 402 405 889 1,513 1,851 1,489 1,603 1,506 2,273 1,985
Book Value per Share		 $12.76 $13.76 $15.16 $20.50 $30.57 $32.81 $36.06 $39.33 $43.58 $53.52 $58.72
Tangible Book Value per Share		 $5.63 $6.09 $5.96 $8.34 $9.20 ($1.39) $0.35 ($1.33) ($2.98) ($6.05) ($0.75)
Total Capital		 145 183 219 286 535 714 795 765 831 1,189 1,206
Total Debt		 2.99 25 43 17 60 195 221 132 124 218 121
Total Long-Term Debt		 1.88 22 40 17 59 194 221 132 124 218 121
Net Debt		 -2.01 16 -11 -53 -52 50 52 52 59 120 39
Capital Expenditures (CapEx)		 2.21 1.71 -0.09 5.35 4.62 6.83 4.65 8.30 9.44 6.02 7.70
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 49 76 50 44 71 -0.31 38 12 -9.90 5.60 38
Debt-free Net Working Capital (DFNWC)		 53 84 104 115 183 145 207 92 55 105 120
Net Working Capital (NWC)		 52 81 101 115 182 144 207 92 55 105 120
Net Nonoperating Expense (NNE)		 0.28 -0.61 2.20 1.81 1.81 2.03 4.14 6.55 7.40 2.47 8.41
Net Nonoperating Obligations (NNO)		 -2.01 16 -11 -53 -52 50 52 52 59 120 39
Total Depreciation and Amortization (D&A)		 4.81 7.00 8.53 9.25 11 13 15 15 15 15 18
Debt-free, Cash-free Net Working Capital to Revenue		 14.47% 18.93% 11.72% 8.55% 10.92% -0.04% 4.37% 1.23% -0.94% 0.49% 2.70%
Debt-free Net Working Capital to Revenue		 15.69% 20.93% 24.34% 22.18% 28.14% 18.93% 23.90% 9.64% 5.18% 9.05% 8.44%
Net Working Capital to Revenue		 15.36% 20.30% 23.61% 22.16% 28.03% 18.80% 23.90% 9.64% 5.18% 9.05% 8.44%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $1.06 $1.06 $1.19 $1.45 $1.83 $2.12 $2.87 $2.90 $3.91 $4.33 $5.31
Adjusted Weighted Average Basic Shares Outstanding		 10.99M 11.29M 11.47M 12.05M 13.82M 15.60M 15.74M 15.86M 16.00M 17.01M 18.05M
Adjusted Diluted Earnings per Share		 $1.04 $1.06 $1.17 $1.41 $1.77 $2.08 $2.81 $2.84 $3.83 $4.23 $5.22
Adjusted Weighted Average Diluted Shares Outstanding		 11.19M 11.35M 11.62M 12.38M 14.25M 15.96M 16.06M 16.18M 16.31M 17.38M 18.39M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 11.12M 11.53M 11.63M 13.18M 13.82M 15.83M 15.95M 16.13M 16.23M 18.17M 18.52M
Normalized Net Operating Profit after Tax (NOPAT)		 12 12 14 18 27 35 49 53 70 76 104
Normalized NOPAT Margin		 3.53% 2.88% 3.32% 3.53% 4.17% 4.60% 5.70% 5.53% 6.60% 6.59% 7.33%
Pre Tax Income Margin		 4.54% 4.03% 4.94% 3.95% 5.11% 5.48% 6.99% 6.33% 7.68% 8.61% 8.96%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 20.39 6.72 5.70 4.55 11.19 13.96 11.36 7.72 8.19 13.28 10.18
NOPAT to Interest Expense		 15.14 4.95 3.17 3.64 8.71 11.03 8.49 5.90 6.30 9.84 7.66
EBIT Less CapEx to Interest Expense		 17.57 5.99 5.71 3.48 9.70 11.81 10.56 6.79 7.34 12.50 9.62
NOPAT Less CapEx to Interest Expense		 12.33 4.22 3.18 2.57 7.22 8.88 7.68 4.97 5.45 9.06 7.10
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Quarterly Metrics And Ratios for Addus HomeCare

This table displays calculated financial ratios and metrics derived from Addus HomeCare's official financial filings.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
DEI Shares Outstanding		 - - - - - - - - - 18,518,271.00 18,664,776.00
DEI Adjusted Shares Outstanding		 - - - - - - - - - 18,518,271.00 18,664,776.00
DEI Earnings Per Adjusted Shares Outstanding		 - - - - - - - - - 1.35 1.48
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 11.86% 11.58% 10.36% 7.04% 7.52% 20.29% 21.79% 25.02% 25.55% 7.67% 8.01%
EBITDA Growth		 29.95% 22.72% 18.54% 11.02% -4.17% 27.25% 24.58% 27.22% 53.12% 10.51% 16.90%
EBIT Growth		 34.38% 27.07% 21.55% 13.63% -3.78% 29.05% 25.61% 26.91% 57.09% 11.66% 18.41%
NOPAT Growth		 28.48% 21.04% 17.56% 10.17% -7.19% 36.60% 25.57% 29.28% 56.45% 9.77% 17.48%
Net Income Growth		 32.62% 24.89% 21.73% 30.84% -0.27% 34.10% 21.98% 13.32% 52.52% 18.09% 25.19%
EPS Growth		 32.22% 24.36% 20.88% 15.79% -10.92% 19.59% 9.09% 12.73% 52.83% 17.24% 24.17%
Operating Cash Flow Growth		 23.70% 105.75% -54.79% 122.75% -65.33% -51.01% 19.75% 5.65% 80.10% 176.35% 77.60%
Free Cash Flow Firm Growth		 -40.08% -196.97% -321.83% 180.28% -414.41% -601.66% -379.73% -655.08% 98.93% 105.88% 105.50%
Invested Capital Growth		 11.77% 9.35% 13.24% -5.69% 42.29% 46.73% 46.95% 51.59% 3.18% 0.66% 0.95%
Revenue Q/Q Growth		 2.08% 1.59% 2.20% 1.00% 2.54% 13.65% 3.47% 3.68% 2.97% -2.54% 3.80%
EBITDA Q/Q Growth		 19.45% -14.23% 9.03% -0.62% 3.10% 13.90% 6.74% 1.49% 24.10% -17.80% 12.92%
EBIT Q/Q Growth		 22.47% -15.46% 10.73% -0.87% 3.70% 13.38% 7.78% 0.15% 28.36% -19.41% 14.29%
NOPAT Q/Q Growth		 24.08% -18.68% 9.81% -0.57% 4.53% 19.69% 0.94% 2.37% 26.50% -16.02% 8.03%
Net Income Q/Q Growth		 27.04% -19.14% 14.21% 11.53% -3.16% 8.72% 3.88% 3.61% 30.35% -15.83% 10.12%
EPS Q/Q Growth		 25.26% -18.49% 13.40% 0.00% -3.64% 9.43% 3.45% 3.33% 30.65% -16.05% 9.56%
Operating Cash Flow Q/Q Growth		 37.93% 28.72% -51.36% 157.93% -78.53% 81.89% 18.89% 127.56% -63.40% 179.09% -23.59%
Free Cash Flow Firm Q/Q Growth		 24.58% 21.51% -47.05% 192.23% -583.25% -7.06% -0.54% -6.71% 99.07% 687.09% -5.93%
Invested Capital Q/Q Growth		 -0.32% -2.38% 0.08% -3.15% 50.39% 0.66% 0.23% -0.09% 2.36% -1.80% 0.53%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 33.44% 31.41% 32.47% 31.82% 34.15% 31.88% 32.59% 32.21% 33.13% 31.87% 32.21%
EBITDA Margin		 11.53% 9.73% 10.39% 10.22% 10.28% 10.30% 10.62% 10.40% 12.53% 10.57% 11.50%
Operating Margin		 10.12% 8.42% 9.12% 8.96% 9.06% 9.04% 9.41% 9.09% 11.33% 9.37% 10.32%
EBIT Margin		 10.12% 8.42% 9.12% 8.96% 9.06% 9.04% 9.41% 9.09% 11.33% 9.37% 10.32%
Profit (Net Income) Margin		 7.08% 5.64% 6.30% 6.96% 6.57% 6.29% 6.31% 6.31% 7.98% 6.89% 7.31%
Tax Burden Percent		 77.22% 74.28% 73.67% 73.89% 74.49% 78.63% 73.64% 75.27% 74.18% 77.30% 73.07%
Interest Burden Percent		 90.65% 90.12% 93.74% 105.14% 97.41% 88.48% 91.05% 92.16% 94.96% 95.18% 97.03%
Effective Tax Rate		 22.78% 25.72% 26.33% 26.11% 25.51% 21.37% 26.36% 24.73% 25.82% 22.70% 26.93%
Return on Invested Capital (ROIC)		 11.40% 9.51% 10.63% 10.05% 8.39% 9.33% 9.56% 10.11% 10.80% 9.53% 10.07%
ROIC Less NNEP Spread (ROIC-NNEP)		 7.77% 3.48% 11.99% 8.63% 7.81% 4.89% 14.10% 12.34% 8.81% 6.71% 5.83%
Return on Net Nonoperating Assets (RNNOA)		 0.64% 0.15% -1.35% -0.73% 0.83% 0.35% -0.69% -1.08% 0.68% 0.29% 0.11%
Return on Equity (ROE)		 12.05% 9.65% 9.29% 9.32% 9.23% 9.68% 8.86% 9.03% 11.48% 9.82% 10.18%
Cash Return on Invested Capital (CROIC)		 -1.48% 1.26% -1.65% 16.25% -26.71% -28.94% -28.58% -30.81% 6.29% 9.04% 9.09%
Operating Return on Assets (OROA)		 10.92% 9.42% 9.95% 9.28% 8.58% 9.04% 9.50% 9.51% 11.31% 9.55% 10.63%
Return on Assets (ROA)		 7.64% 6.31% 6.87% 7.21% 6.23% 6.29% 6.37% 6.59% 7.97% 7.02% 7.54%
Return on Common Equity (ROCE)		 12.05% 9.65% 9.29% 9.32% 9.23% 9.68% 8.86% 9.03% 11.48% 9.82% 10.18%
Return on Equity Simple (ROE_SIMPLE)		 0.00% 9.06% 7.48% 7.77% 0.00% 7.94% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 22 18 19 19 20 24 24 25 31 26 28
NOPAT Margin		 7.82% 6.26% 6.72% 6.62% 6.75% 7.10% 6.93% 6.84% 8.41% 7.24% 7.54%
Net Nonoperating Expense Percent (NNEP)		 3.63% 6.03% -1.35% 1.42% 0.58% 4.44% -4.54% -2.23% 1.99% 2.82% 4.24%
Return On Investment Capital (ROIC_SIMPLE)		 2.60% - - - 1.69% 2.01% 2.03% 2.07% 2.60% 2.18% 2.35%
Cost of Revenue to Revenue		 66.56% 68.59% 67.53% 68.18% 65.85% 68.12% 67.41% 67.79% 66.87% 68.13% 67.79%
SG&A Expenses to Revenue		 21.99% 21.75% 22.16% 21.67% 24.01% 21.68% 22.06% 21.91% 20.69% 21.39% 20.80%
R&D to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 23.32% 22.99% 23.34% 22.86% 25.10% 22.85% 23.18% 23.12% 21.80% 22.50% 21.89%
Earnings before Interest and Taxes (EBIT)		 28 24 26 26 27 31 33 33 42 34 39
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 32 27 30 30 31 35 37 38 47 38 43
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 2.13 2.31 2.06 2.54 2.34 1.81 2.07 2.07 1.83 1.55 1.63
Price to Tangible Book Value (P/TBV)		 0.00 0.00 11.22 12.20 0.00 0.00 0.00 0.00 0.00 91.31 46.07
Price to Revenue (P/Rev)		 1.42 1.54 1.71 2.12 1.97 1.48 1.66 1.61 1.40 1.20 1.27
Price to Earnings (P/E)		 24.08 25.52 27.59 32.69 30.88 22.75 25.54 25.36 20.70 17.39 17.81
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 4.15% 3.92% 3.62% 3.06% 3.24% 4.40% 3.91% 3.94% 4.83% 5.75% 5.62%
Enterprise Value to Invested Capital (EV/IC)		 2.04 2.27 2.31 3.01 2.19 1.73 2.00 2.02 1.80 1.56 1.65
Enterprise Value to Revenue (EV/Rev)		 1.48 1.56 1.55 1.93 2.07 1.57 1.72 1.65 1.42 1.19 1.24
Enterprise Value to EBITDA (EV/EBITDA)		 14.77 15.30 14.94 18.42 20.40 15.23 16.64 15.85 12.95 10.77 11.05
Enterprise Value to EBIT (EV/EBIT)		 17.20 17.69 17.17 21.06 23.30 17.33 18.90 18.02 14.60 12.12 12.40
Enterprise Value to NOPAT (EV/NOPAT)		 22.38 23.27 22.78 28.16 31.45 23.05 25.16 23.88 19.41 16.14 16.56
Enterprise Value to Operating Cash Flow (EV/OCF)		 13.94 12.85 15.80 16.06 20.55 19.64 21.88 21.53 18.15 11.89 11.31
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 187.95 0.00 18.01 0.00 0.00 0.00 0.00 29.04 17.31 18.29
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.18 0.14 0.00 0.00 0.23 0.20 0.17 0.14 0.11 0.08 0.05
Long-Term Debt to Equity		 0.18 0.14 0.00 0.00 0.23 0.20 0.17 0.14 0.11 0.08 0.05
Financial Leverage		 0.08 0.04 -0.11 -0.09 0.11 0.07 -0.05 -0.09 0.08 0.04 0.02
Leverage Ratio		 1.46 1.42 1.29 1.34 1.45 1.41 1.30 1.29 1.39 1.35 1.32
Compound Leverage Factor		 1.33 1.28 1.21 1.41 1.42 1.25 1.18 1.19 1.32 1.28 1.28
Debt to Total Capital		 14.94% 12.05% 0.00% 0.00% 18.37% 16.64% 14.20% 12.55% 10.03% 7.56% 5.09%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 14.94% 12.05% 0.00% 0.00% 18.37% 16.64% 14.20% 12.55% 10.03% 7.56% 5.09%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 85.06% 87.95% 100.00% 100.00% 81.63% 83.36% 85.80% 87.45% 89.97% 92.44% 94.91%
Debt to EBITDA		 1.17 0.90 0.00 0.00 1.86 1.59 1.28 1.08 0.77 0.57 0.37
Net Debt to EBITDA		 0.56 0.20 0.00 0.00 1.02 0.82 0.59 0.35 0.25 -0.07 -0.23
Long-Term Debt to EBITDA		 1.17 0.90 0.00 0.00 1.86 1.59 1.28 1.08 0.77 0.57 0.37
Debt to NOPAT		 1.78 1.36 0.00 0.00 2.87 2.41 1.94 1.62 1.16 0.86 0.56
Net Debt to NOPAT		 0.85 0.31 0.00 0.00 1.57 1.24 0.89 0.52 0.38 -0.11 -0.34
Long-Term Debt to NOPAT		 1.78 1.36 0.00 0.00 2.87 2.41 1.94 1.62 1.16 0.86 0.56
Altman Z-Score		 4.44 5.13 7.51 8.71 4.43 4.04 4.78 5.04 5.03 4.93 5.35
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 1.38 1.35 2.00 2.11 1.67 1.74 1.74 1.66 1.80 1.83 1.69
Quick Ratio		 1.24 1.28 1.91 2.02 1.42 1.57 1.53 1.50 1.56 1.66 1.46
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -59 -46 -68 63 -304 -325 -327 -349 -3.26 19 18
Operating Cash Flow to CapEx		 566.43% 2,865.04% 1,756.58% 2,524.71% 613.91% 1,010.07% 1,813.93% 2,656.27% 706.44% 3,094.86% 3,024.26%
Free Cash Flow to Firm to Interest Expense		 -18.97 -16.82 -32.26 109.77 -132.90 -80.99 -92.81 -104.43 -1.20 8.90 10.44
Operating Cash Flow to Interest Expense		 9.65 14.02 8.90 84.69 4.56 4.72 6.39 15.34 6.88 24.34 23.21
Operating Cash Flow Less CapEx to Interest Expense		 7.94 13.53 8.39 81.33 3.81 4.25 6.04 14.76 5.91 23.56 22.44
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 1.08 1.12 1.09 1.04 0.95 1.00 1.01 1.05 1.00 1.02 1.03
Accounts Receivable Turnover		 8.79 9.45 10.45 10.42 9.69 10.12 10.22 11.68 10.36 10.37 10.35
Inventory Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover		 46.85 49.31 51.86 51.27 47.40 49.89 53.28 55.92 57.24 58.69 61.15
Accounts Payable Turnover		 29.78 33.72 36.90 31.28 29.22 32.69 47.88 40.85 43.66 46.58 59.22
Days Sales Outstanding (DSO)		 41.55 38.62 34.94 35.04 37.68 36.05 35.71 31.26 35.23 35.21 35.26
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)		 12.26 10.82 9.89 11.67 12.49 11.17 7.62 8.94 8.36 7.84 6.16
Cash Conversion Cycle (CCC)		 29.29 27.79 25.05 23.37 25.19 24.89 28.09 22.32 26.87 27.37 29.09
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 766 748 748 725 1,090 1,097 1,100 1,099 1,125 1,104 1,110
Invested Capital Turnover		 1.46 1.52 1.58 1.52 1.24 1.31 1.38 1.48 1.28 1.32 1.34
Increase / (Decrease) in Invested Capital		 81 64 87 -44 324 349 351 374 35 7.20 10
Enterprise Value (EV)		 1,565 1,698 1,727 2,185 2,393 1,899 2,197 2,221 2,024 1,722 1,837
Market Capitalization		 1,506 1,676 1,901 2,408 2,273 1,797 2,119 2,172 1,985 1,734 1,875
Book Value per Share		 $43.58 $45.14 $56.30 $52.35 $53.52 $54.77 $55.54 $57.04 $58.72 $61.35 $61.51
Tangible Book Value per Share		 ($2.98) ($1.77) $10.35 $10.91 ($6.05) ($4.66) ($2.91) ($2.34) ($0.75) $1.04 $2.18
Total Capital		 831 824 922 948 1,189 1,194 1,191 1,201 1,206 1,207 1,210
Total Debt		 124 99 0.00 0.00 218 199 169 151 121 91 62
Total Long-Term Debt		 124 99 0.00 0.00 218 199 169 151 121 91 62
Net Debt		 59 23 -173 -223 120 102 78 49 39 -12 -38
Capital Expenditures (CapEx)		 5.31 1.35 1.07 1.92 1.70 1.88 1.24 1.93 2.66 1.69 1.32
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -9.90 -26 -26 -48 5.60 13 20 1.95 38 20 16
Debt-free Net Working Capital (DFNWC)		 55 50 147 175 105 110 112 104 120 123 116
Net Working Capital (NWC)		 55 50 147 175 105 110 112 104 120 123 116
Net Nonoperating Expense (NNE)		 2.02 1.73 1.21 -0.99 0.52 2.76 2.17 1.94 1.58 1.27 0.85
Net Nonoperating Obligations (NNO)		 59 23 -173 -223 120 102 78 49 39 -12 -38
Total Depreciation and Amortization (D&A)		 3.89 3.68 3.62 3.66 3.62 4.26 4.23 4.74 4.48 4.36 4.45
Debt-free, Cash-free Net Working Capital to Revenue		 -0.94% -2.43% -2.32% -4.22% 0.49% 1.07% 1.61% 0.14% 2.70% 1.40% 1.11%
Debt-free Net Working Capital to Revenue		 5.18% 4.62% 13.23% 15.43% 9.05% 9.07% 8.76% 7.71% 8.44% 8.52% 7.86%
Net Working Capital to Revenue		 5.18% 4.62% 13.23% 15.43% 9.05% 9.07% 8.76% 7.71% 8.44% 8.52% 7.86%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $1.23 $0.99 $1.12 $1.13 $1.09 $1.18 $1.22 $1.26 $1.65 $1.38 $1.51
Adjusted Weighted Average Basic Shares Outstanding		 16.00M 16.06M 16.18M 17.87M 17.01M 17.98M 18.05M 18.07M 18.05M 18.19M 18.29M
Adjusted Diluted Earnings per Share		 $1.19 $0.97 $1.10 $1.10 $1.06 $1.16 $1.20 $1.24 $1.62 $1.36 $1.49
Adjusted Weighted Average Diluted Shares Outstanding		 16.31M 16.37M 16.50M 18.26M 17.38M 18.31M 18.33M 18.39M 18.39M 18.49M 18.47M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 16.23M 16.37M 18.10M 18.13M 18.17M 18.40M 18.41M 18.48M 18.52M 18.66M 18.67M
Normalized Net Operating Profit after Tax (NOPAT)		 22 18 19 19 20 24 24 25 31 26 28
Normalized NOPAT Margin		 7.82% 6.26% 6.72% 6.62% 6.75% 7.10% 6.93% 6.84% 8.41% 7.24% 7.54%
Pre Tax Income Margin		 9.17% 7.59% 8.55% 9.42% 8.82% 7.99% 8.57% 8.38% 10.76% 8.92% 10.01%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 8.98 8.57 12.38 45.29 11.77 7.59 9.33 9.85 15.51 15.84 22.59
NOPAT to Interest Expense		 6.93 6.37 9.12 33.47 8.77 5.97 6.87 7.42 11.50 12.24 16.50
EBIT Less CapEx to Interest Expense		 7.28 8.08 11.88 41.94 11.03 7.13 8.98 9.28 14.53 15.05 21.82
NOPAT Less CapEx to Interest Expense		 5.23 5.88 8.62 30.11 8.02 5.50 6.52 6.84 10.53 11.46 15.74
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Financials Breakdown Chart

Key Financial Trends

Addus HomeCare (NASDAQ: ADUS) showed solid top-line growth and strong profitability in Q1 2026, but the quarter also continued a pattern of heavier acquisitions, higher goodwill/intangible balances, and rising leverage compared with a year ago.

Revenue in Q1 2026 rose to $363.6 million, up from $337.7 million in Q1 2025. Gross profit increased to $115.9 million, and operating income improved to $34.1 million. Net income came in at $25.1 million, or $1.36 diluted EPS, versus $21.2 million and $1.16 diluted EPS in the prior-year quarter.

Cash flow also remained healthy. Addus generated $52.4 million in operating cash flow in Q1 2026, up sharply from $18.9 million in Q1 2025. That is a strong sign that earnings are being backed by real cash generation, even after working capital swings. The company also ended Q1 2026 with $103.1 million in cash and equivalents.

At the same time, the balance sheet shows the company is leaning more on acquisitions and goodwill growth. Goodwill increased to $996.7 million from $972.3 million at the start of the year and $663.4 million a year earlier, while intangible assets also remain large. Long-term debt stood at $91.3 million, down from $198.7 million in Q1 2025, but still a meaningful obligation.

Over the last four years, Addus has posted consistent revenue growth, improved earnings, and strong cash generation. However, the business mix and balance sheet have been shaped by acquisitions, which have expanded asset value and increased goodwill substantially. Investors should watch whether future growth continues to translate into margin expansion and sustained operating cash flow, not just purchased growth.

  • Revenue growth remains intact: Q1 2026 revenue rose 7.7% year over year to $363.6 million.
  • Profitability improved: Net income increased to $25.1 million from $21.2 million a year ago.
  • Operating cash flow was very strong: Q1 2026 operating cash flow reached $52.4 million versus $18.9 million in Q1 2025.
  • Liquidity is solid: Cash and equivalents totaled $103.1 million at quarter-end.
  • Debt has come down materially from last year: Long-term debt fell to $91.3 million from $198.7 million in Q1 2025.
  • Margins were broadly stable: Gross margin and operating margin remained healthy, but not dramatically better than recent quarters.
  • Share count is still rising gradually: Diluted shares increased modestly year over year, which can limit EPS growth.
  • Acquisitions remain a core growth driver: Recent results suggest management is still using M&A to expand the business.
  • Goodwill is very large: Goodwill reached nearly $1.0 billion, increasing the risk of future impairment if acquisitions underperform.
  • Intangibles remain elevated: The balance sheet still carries more than $100 million in intangible assets.
  • Working capital can be volatile: Operating cash flow benefited from favorable changes in operating assets and liabilities this quarter, which may not repeat every period.

Bottom line: Addus HomeCare continues to look like a profitable, cash-generative healthcare services company with steady growth. The main caution is that a large portion of the balance sheet reflects acquisition-related assets, so investors should keep an eye on integration performance, leverage, and whether cash flow stays strong after working capital normalizes.

08/10/26 11:41 AM ETAI Generated. May Contain Errors.

Addus HomeCare Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Addus HomeCare's fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

Addus HomeCare's net income appears to be on an upward trend, with a most recent value of $95.91 million in 2025, rising from $11.62 million in 2015. The previous period was $73.60 million in 2024. Check out Addus HomeCare's forecast to explore projected trends and price targets.

Addus HomeCare's total operating income in 2025 was $138.62 million, based on the following breakdown:
  • Total Gross Profit: $461.87 million
  • Total Operating Expenses: $323.26 million

Over the last 10 years, Addus HomeCare's total revenue changed from $336.82 million in 2015 to $1.42 billion in 2025, a change of 322.3%.

Addus HomeCare's total liabilities were at $352.01 million at the end of 2025, a 20.4% decrease from 2024, and a 698.7% increase since 2015.

In the past 10 years, Addus HomeCare's cash and equivalents has ranged from $4.10 million in 2015 to $168.90 million in 2021, and is currently $81.62 million as of their latest financial filing in 2025.

Over the last 10 years, Addus HomeCare's book value per share changed from 12.76 in 2015 to 58.72 in 2025, a change of 360.2%.


Related Companies

Financial statements for NASDAQ:ADUS last updated on 8/4/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel
Your $29.97 book is free today
Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...
Profits Run | Sponsoredtc pixel
Barricks gold output fell from 2 million ounces to 719000
Barrick's gold production has plunged from 2 million ounces to just 719,000, leaving the world's second-larges...
Golden Portfolio | Sponsoredtc pixel
The $15 Gold Fund That Pays Up to $1,152/Month
Gold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...
Investors Alley | Sponsoredtc pixel
Beginner’s Guide to Gold
The Ultimate Beginner's Guide to Gold IRAs Protect Your Retirement Savings Before It's Too Late With This I...
Goldco Direct, LLC | Sponsoredtc pixel
China is not hedging. It's escaping.
China's US Treasury holdings have fallen from a peak of $1.32 trillion to roughly $659 billion, an 18-year low...
Behind the Markets | Sponsoredtc pixel
The ultimate IPO unicorn
Anthropic is now worth more than a trillion dollars, making it the first private company to reach that milesto...
Weiss Ratings | Sponsoredtc pixel
Free Stock Pick: The Company First in Line for America’s New Super Fuel
The U.S. Army and Department of Energy are launching Project Janus - a high-priority initiative ordered by Pre...
Banyan Hill Publishing | Sponsoredtc pixel